{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T19:15:09Z","timestamp":1787858109933,"version":"build-2784847793"},"reference-count":132,"publisher":"Elsevier","isbn-type":[{"value":"9780443345258","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.irn.2026.05.016","type":"book-chapter","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T19:40:00Z","timestamp":1783194000000},"page":"231-271","source":"Crossref","is-referenced-by-count":1,"title":["Brain energy crisis in Alzheimer\u2019s and Parkinson\u2019s disease: Nanotechnology as a therapeutic strategy"],"prefix":"10.1016","author":[{"given":"Mohini","family":"Milmile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajanan","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradnya","family":"Petkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.irn.2026.05.016_bib1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/ph15030370","article-title":"Design and development of levodopa loaded polymeric nanoparticles for intranasal delivery","volume":"15","author":"Ahmad","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.irn.2026.05.016_bib2","series-title":"Apolipoprotein E","first-page":"1","article-title":"Therapeutic use of ApoE-mimetic peptides","author":"Ahmed","year":"2025"},{"key":"10.1016\/bs.irn.2026.05.016_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3390\/jpm12050673","article-title":"The promise of nanotechnology in personalized medicine","volume":"12","author":"Alghamdi","year":"2022","journal-title":"Journal of Personalized Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/cells15040372","article-title":"Mitochondria at the crossroads of cardiovascular disease: Mechanistic drivers and emerging therapeutic strategies","volume":"15","author":"Alia","year":"2026","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.05.016_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD+ in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Molecular Metabolism"},{"key":"10.1016\/bs.irn.2026.05.016_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/ars.2014.5952","article-title":"Molecular strategies for targeting antioxidants to mitochondria: Therapeutic implications","volume":"22","author":"Apostolova","year":"2015","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/bs.irn.2026.05.016_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102838","article-title":"Regulation and function of the mammalian tricarboxylic acid cycle","volume":"299","author":"Arnold","year":"2023","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib9","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/pharmaceutics12121230","article-title":"Intranasal nanoemulsions for direct nose-to-brain delivery of actives for CNS Disorders","volume":"12","author":"Bahadur","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/bc700184b","article-title":"A macrophage\u2212nanozyme delivery system for Parkinson\u2019s disease","volume":"18","author":"Batrakova","year":"2007","journal-title":"Bioconjugate Chemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0005-2728(98)00114-5","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"1366","author":"Beal","year":"1998","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"10.1016\/bs.irn.2026.05.016_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nature Genetics"},{"key":"10.1016\/bs.irn.2026.05.016_bib13","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.1074\/jbc.M110.180638","article-title":"Naturally secreted amyloid-\u03b2 increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism","volume":"286","author":"Caccamo","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2025.e00722","article-title":"Engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in Alzheimer\u2019s disease: Rational design, blood-brain barrier penetration, and multi-target therapeutic synergy","volume":"22","author":"Chen","year":"2025","journal-title":"Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117084","article-title":"New insights into the role of mitochondrial dynamics in oxidative stress-induced diseases","volume":"178","author":"Chen","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.irn.2026.05.016_bib16","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/mds.25978","article-title":"Systemic exosomal siRNA delivery reduced alpha\u2010synuclein aggregates in brains of transgenic mice","volume":"29","author":"Cooper","year":"2014","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2026.05.016_bib17","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1590\/1980-57642015DN94000385","article-title":"Analysis of the posterior cingulate cortex with [18 F]FDG-PET and Naa\/mI in mild cognitive impairment and Alzheimer\u2019s disease: Correlations and differences between the two methods","volume":"9","author":"Coutinho","year":"2015","journal-title":"Dementia & Neuropsychologia"},{"key":"10.1016\/bs.irn.2026.05.016_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41580-020-00313-x","article-title":"NAD+ metabolism and its roles in cellular processes during ageing","volume":"22","author":"Covarrubias","year":"2021","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.irn.2026.05.016_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12999","article-title":"Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer\u2019s disease","volume":"1367","author":"Cunnane","year":"2016","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib20","article-title":"Crossing the blood\u2013brain barrier with molecularly imprinted polymeric nanocarriers: An emerging frontier in brain disease therapy","volume":"13","author":"De","year":"2026","journal-title":"Advanced Science"},{"key":"10.1016\/bs.irn.2026.05.016_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5497\/wjp.v4.i3.236","article-title":"Therapeutic targets and delivery challenges for Alzheimer\u2019s disease","volume":"4","author":"Desai","year":"2015","journal-title":"World Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2026.05.016_bib22","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.3390\/cells11152364","article-title":"Mitochondrial damage-associated molecular patterns content in extracellular vesicles promotes early inflammation in neurodegenerative disorders","volume":"11","author":"Deus","year":"2022","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.05.016_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","article-title":"Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1471-4159.1989.tb07264.x","article-title":"Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson\u2019s disease","volume":"52","author":"Dexter","year":"1989","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3390\/gels11110846","article-title":"Cell membrane- and vesicle-based bionic nanodrugs: Applications in central nervous system diseases and exploration of nasal\u2013Cerebral delivery","volume":"11","author":"Ding","year":"2025","journal-title":"Gels"},{"key":"10.1016\/bs.irn.2026.05.016_bib26","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3233\/JAD-2012-112141","article-title":"Neuronal uptake and neuroprotective effect of curcumin-loaded PLGA nanoparticles on the human SK-N-SH cell line","volume":"30","author":"Doggui","year":"2012","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1016\/bs.irn.2026.05.016_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-025-00481-w","article-title":"Nose-to-brain drug delivery: From bench to bedside","volume":"14","author":"Drath","year":"2025","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/bs.irn.2026.05.016_bib28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/pharmaceutics12050448","article-title":"Neuroprotective effect of ropinirole lipid nanoparticles enriched hydrogel for Parkinson\u2019s disease: In vitro, ex vivo, pharmacokinetic and pharmacodynamic evaluation","volume":"12","author":"Dudhipala","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib29","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1038\/nprot.2012.131","article-title":"Exosome-mediated delivery of siRNA in vitro and in vivo","volume":"7","author":"El-Andaloussi","year":"2012","journal-title":"Nature Protocols"},{"key":"10.1016\/bs.irn.2026.05.016_bib30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/pharmaceutics15020533","article-title":"Investigating the targeting power to brain tissues of intranasal rasagiline mesylate-loaded transferosomal in situ gel for efficient treatment of Parkinson\u2019s disease","volume":"15","author":"ElShagea","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib31","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11095-007-9514-y","article-title":"Solid lipid nanoparticles as delivery systems for bromocriptine","volume":"25","author":"Esposito","year":"2008","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib32","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1016\/j.ymthe.2022.06.003","article-title":"MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson\u2019s disease","volume":"30","author":"Esteves","year":"2022","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.irn.2026.05.016_bib33","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1080\/10717544.2018.1461955","article-title":"Curcumin-loaded PLGA-PEG nanoparticles conjugated with B6 peptide for potential use in Alzheimer\u2019s disease","volume":"25","author":"Fan","year":"2018","journal-title":"Drug Delivery"},{"key":"10.1016\/bs.irn.2026.05.016_bib34","doi-asserted-by":"crossref","first-page":"12076","DOI":"10.1039\/C5NR03474D","article-title":"Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases","volume":"7","author":"Fornaguera","year":"2015","journal-title":"Nanoscale"},{"key":"10.1016\/bs.irn.2026.05.016_bib35","doi-asserted-by":"crossref","DOI":"10.1242\/bio.022863","article-title":"An AMPK-dependent regulatory pathway in tau-mediated toxicity","author":"Galasso","year":"2017","journal-title":"Biology Open"},{"key":"10.1016\/bs.irn.2026.05.016_bib36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12987-026-00760-2","article-title":"Bridging the blood-brain barrier: Strategies to improve delivery of biologics to tumors in the brain","volume":"23","author":"Gampa","year":"2026","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/bs.irn.2026.05.016_bib37","doi-asserted-by":"crossref","first-page":"10482","DOI":"10.1039\/D3TB01763J","article-title":"Albumin\u2013manganese dioxide nanocomposites: A potent inhibitor and ROS scavenger against Alzheimer\u2019s \u03b2-amyloid fibrillogenesis and neuroinflammation","volume":"11","author":"Gao","year":"2023","journal-title":"Journal of Materials Chemistry B"},{"key":"10.1016\/bs.irn.2026.05.016_bib38","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1021\/acsami.1c17861","article-title":"Gold nanorods with spatial separation of CeO 2 deposition for plasmonic-enhanced antioxidant stress and photothermal therapy of Alzheimer\u2019s disease","volume":"14","author":"Ge","year":"2022","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/bs.irn.2026.05.016_bib39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2478\/jtim-2021-0054","article-title":"The long and the short of current nanomedicines for treating Alzheimer\u2019s disease","volume":"10","author":"Gong","year":"2023","journal-title":"Journal of Translational Internal Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2015.03.033","article-title":"Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy","volume":"207","author":"Haney","year":"2015","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.irn.2026.05.016_bib41","doi-asserted-by":"crossref","first-page":"19682","DOI":"10.1021\/acsomega.5c00691","article-title":"A levodopa-encapsulated poly-\u03b5-caprolactone nanocomposite improves the motor symptoms and neurochemical changes in a rotenone-induced mouse model of Parkinson\u2019s disease","volume":"10","author":"Hanumanthappa","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/bs.irn.2026.05.016_bib42","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/ijo.2008.116","article-title":"AMPK: A key regulator of energy balance in the single cell and the whole organism","volume":"32","author":"Hardie","year":"2008","journal-title":"International Journal of Obesity"},{"key":"10.1016\/bs.irn.2026.05.016_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: A nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.irn.2026.05.016_bib44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","article-title":"NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice","volume":"493","author":"Heneka","year":"2013","journal-title":"Nature"},{"key":"10.1016\/bs.irn.2026.05.016_bib45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2174\/1381612822666151221150733","article-title":"Evolving drug delivery strategies to overcome the blood brain barrier","volume":"22","author":"Hersh","year":"2016","journal-title":"Current Pharmaceutical Design"},{"key":"10.1016\/bs.irn.2026.05.016_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review","volume":"15","author":"Hossen","year":"2019","journal-title":"Journal of Advanced Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrm3293","article-title":"Sirtuins as regulators of metabolism and healthspan","volume":"13","author":"Houtkooper","year":"2012","journal-title":"Nature Reviews. Molecular Cell Biology"},{"key":"10.1016\/bs.irn.2026.05.016_bib48","doi-asserted-by":"crossref","first-page":"6797","DOI":"10.2147\/IJN.S434873","article-title":"Functionalized cerium dioxide nanoparticles with antioxidative neuroprotection for Alzheimer\u2019s disease","volume":"18","author":"Hu","year":"2023","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib49","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","article-title":"Systemic exosomal delivery of shRNA minicircles prevents parkinsonian pathology","volume":"27","author":"Izco","year":"2019","journal-title":"Molecular Therapy"},{"key":"10.1016\/bs.irn.2026.05.016_bib50","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/bs.irn.2026.05.016_bib51","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3390\/ph17060720","article-title":"Box-Behnken design-based optimization and evaluation of lipid-based nano drug delivery system for brain targeting of bromocriptine","volume":"17","author":"K M","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.irn.2026.05.016_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12951-024-02406-7","article-title":"Neuromodulation by nanozymes and ultrasound during Alzheimer\u2019s disease management","volume":"22","author":"Karthika","year":"2024","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/1570159X20666220507022701","article-title":"Nanotechnological advances for nose to brain delivery of therapeutics to improve the Parkinson therapy","volume":"21","author":"Khatri","year":"2023","journal-title":"Current Neuropharmacology"},{"key":"10.1016\/bs.irn.2026.05.016_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7877265","article-title":"Development, statistical optimization, and characterization of resveratrol\u2010containing solid lipid nanoparticles (SLNs) and determination of the efficacy in reducing neurodegenerative symptoms related to Alzheimer\u2019s disease: In vitro and in vivo study","volume":"2024","author":"Khishvand","year":"2024","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.irn.2026.05.016_bib55","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/jcm14020386","article-title":"The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: Mechanisms of disruption and therapeutic implications","volume":"14","author":"Kim","year":"2025","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1586\/erm.13.15","article-title":"Nanotheranostics for personalized medicine","volume":"13","author":"Kim","year":"2013","journal-title":"Expert Review of Molecular Diagnostics"},{"key":"10.1016\/bs.irn.2026.05.016_bib57","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/s41467-018-03733-8","article-title":"Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson\u2019s disease treatment","volume":"9","author":"Kojima","year":"2018","journal-title":"Nature Communications"},{"key":"10.1016\/bs.irn.2026.05.016_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12916-021-02185-0","article-title":"Ketone bodies: From enemy to friend and guardian angel","volume":"19","author":"Kolb","year":"2021","journal-title":"BMC Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib59","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2147\/IJN.S439181","article-title":"Recent advances in intranasal administration for brain-targeting delivery: A comprehensive review of lipid-based nanoparticles and stimuli-responsive gel formulations","volume":"19","author":"Koo","year":"2024","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib60","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1093\/nar\/gkm635","article-title":"The ageing mitochondrial genome","volume":"35","author":"Krishnan","year":"2007","journal-title":"Nucleic Acids Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib61","doi-asserted-by":"crossref","first-page":"10357","DOI":"10.3390\/ijms251910357","article-title":"Vivo evaluation of nose-to-brain delivery of liposomal donepezil, memantine, and BACE-1 siRNA for Alzheimer\u2019s disease therapy","volume":"25","author":"Lee","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1450","article-title":"Stimuli\u2010responsive liposomes for drug delivery","volume":"9","author":"Lee","year":"2017","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib63","doi-asserted-by":"crossref","first-page":"23536","DOI":"10.1021\/acsami.4c22181","article-title":"Biomimetic nanoparticles enhance recovery of movement disorders in Parkinson\u2019s disease by improving microglial mitochondrial homeostasis and suppressing neuroinflammation","volume":"17","author":"Li","year":"2025","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/bs.irn.2026.05.016_bib64","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ajps.2019.06.003","article-title":"Redox dual-stimuli responsive drug delivery systems for improving tumor-targeting ability and reducing adverse side effects","volume":"15","author":"Li","year":"2020","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib65","article-title":"Advancements in mitochondrial-targeted nanotherapeutics: Overcoming biological obstacles and optimizing drug delivery","volume":"15","author":"Li","year":"2024","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.irn.2026.05.016_bib66","doi-asserted-by":"crossref","first-page":"13968","DOI":"10.1021\/acsami.1c00157","article-title":"Yb 3+, Er 3+ codoped cerium oxide upconversion nanoparticles enhanced the enzymelike catalytic activity and antioxidative activity for Parkinson\u2019s disease treatment","volume":"13","author":"Li","year":"2021","journal-title":"ACS Applied Materials & Interfaces"},{"key":"10.1016\/bs.irn.2026.05.016_bib67","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1021\/mp4001662","article-title":"Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells","volume":"10","author":"Lin","year":"2013","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib68","article-title":"Reactive oxygen species-responsive polymer drug delivery systems","volume":"11","author":"Liu","year":"2023","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202106723","article-title":"Prussian blue nanozyme as a pyroptosis inhibitor alleviates neurodegeneration","volume":"34","author":"Ma","year":"2022","journal-title":"Advanced Materials"},{"key":"10.1016\/bs.irn.2026.05.016_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032616","article-title":"Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease","volume":"7","author":"Mathew","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.irn.2026.05.016_bib71","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/03639045.2012.758130","article-title":"Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting","volume":"40","author":"Md","year":"2014","journal-title":"Drug Development and Industrial Pharmacy"},{"key":"10.1016\/bs.irn.2026.05.016_bib72","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2013.07.001","article-title":"Sugar for the brain: The role of glucose in physiological and pathological brain function","volume":"36","author":"Mergenthaler","year":"2013","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib73","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.irn.2026.05.016_bib74","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10.1016\/bs.irn.2026.05.016_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18 F-FDG PET diagnosis of mild cognitive impairment, Alzheimer\u2019s disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib76","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nmat3776","article-title":"Stimuli-responsive nanocarriers for drug delivery","volume":"12","author":"Mura","year":"2013","journal-title":"Nature Materials"},{"key":"10.1016\/bs.irn.2026.05.016_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","article-title":"Targeting antioxidants to mitochondria by conjugation to lipophilic cations","volume":"47","author":"Murphy","year":"2007","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.irn.2026.05.016_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117372","article-title":"Biophysical translational paradigm of polymeric nanoparticle: Embarked advancement to brain tumor therapy","volume":"179","author":"Naser","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.irn.2026.05.016_bib79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2010.05.084","article-title":"Regional cerebral glucose uptake in the 3xTG model of Alzheimer\u2019s disease highlights common regional vulnerability across AD mouse models","volume":"1347","author":"Nicholson","year":"2010","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/17425247.2025.2569644","article-title":"Can nanoparticle-based intranasal delivery systems revolutionize treatment of central nervous system diseases?","volume":"23","author":"Nunziata","year":"2026","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/bs.irn.2026.05.016_bib81","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2\u00a0polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2026.05.016_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajps.2023.100883","article-title":"Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers","volume":"19","author":"Ouyang","year":"2024","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib83","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","article-title":"Drug transport across the blood\u2013brain barrier","volume":"32","author":"Pardridge","year":"2012","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"key":"10.1016\/bs.irn.2026.05.016_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202207238","article-title":"Brain\u2010penetrating and disease site\u2010targeting manganese dioxide\u2010polymer\u2010lipid hybrid nanoparticles remodel microenvironment of Alzheimer\u2019s disease by regulating multiple pathological pathways","volume":"10","author":"Park","year":"2023","journal-title":"Advanced Science"},{"key":"10.1016\/bs.irn.2026.05.016_bib85","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/08982104.2018.1552703","article-title":"Nanostructured cubosomes in an in situ nasal gel system: An alternative approach for the controlled delivery of donepezil HCl to brain","volume":"29","author":"Patil","year":"2019","journal-title":"Journal of Liposome Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115195","article-title":"Unlocking the mitochondria for nanomedicine-based treatments: Overcoming biological barriers, improving designs, and selecting verification techniques","volume":"207","author":"Pegoraro","year":"2024","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/bs.irn.2026.05.016_bib87","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, Parkin, and mitochondrial fidelity in Parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/bs.irn.2026.05.016_bib88","doi-asserted-by":"crossref","first-page":"20432","DOI":"10.1039\/C4RA16265J","article-title":"Ceria nanoparticles for the treatment of Parkinson-like diseases induced by chronic manganese intoxication","volume":"5","author":"Pinna","year":"2015","journal-title":"RSC Advances"},{"key":"10.1016\/bs.irn.2026.05.016_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jconrel.2018.08.035","article-title":"Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson\u2019s disease","volume":"287","author":"Qu","year":"2018","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.irn.2026.05.016_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/pharmaceutics13010037","article-title":"Redox-responsive nanocarrier for controlled release of drugs in inflammatory skin diseases","volume":"13","author":"Rajes","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib91","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/s12249-022-02209-9","article-title":"Donepezil HCl liposomes: Development, characterization, cytotoxicity, and pharmacokinetic study","volume":"23","author":"Rajput","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/bs.irn.2026.05.016_bib92","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/cells12162019","article-title":"Hypometabolism, Alzheimer\u2019s disease, and possible therapeutic targets: An overview","volume":"12","author":"Raut","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.irn.2026.05.016_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","article-title":"Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer\u2019s disease","volume":"14","author":"Reddy","year":"2008","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib94","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2018.04.035","article-title":"A novel peptide ligand RAP12 of LRP1 for glioma targeted drug delivery","volume":"279","author":"Ruan","year":"2018","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.irn.2026.05.016_bib95","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3390\/nano10020235","article-title":"Cerium oxide nanoparticles rescue \u03b1-synuclein-induced toxicity in a yeast model of Parkinson\u2019s disease","volume":"10","author":"Ruotolo","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/bs.irn.2026.05.016_bib96","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1021\/acschemneuro.8b00510","article-title":"Brain delivery of curcumin using solid lipid nanoparticles and nanostructured lipid carriers: Preparation, optimization, and pharmacokinetic evaluation","volume":"10","author":"Sadegh Malvajerd","year":"2019","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.016_bib97","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: Overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"Journal of Controlled Release"},{"key":"10.1016\/bs.irn.2026.05.016_bib98","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"168","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1016\/bs.irn.2026.05.016_bib99","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/bs.irn.2026.05.016_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156300","article-title":"Overview of methods that determine mitochondrial function in human disease","volume":"170","author":"Sharma","year":"2025","journal-title":"Metabolism: Clinical and Experimental"},{"key":"10.1016\/bs.irn.2026.05.016_bib101","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.2147\/IJN.S417928","article-title":"Combined donepezil with astaxanthin via nanostructured lipid carriers effective delivery to brain for Alzheimer\u2019s disease in rat model","volume":"18","author":"Shehata","year":"2023","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib102","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: A bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"Journal of Nanoscience and Nanotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1991","article-title":"Targeting specific brain districts for advanced nanotherapies: A review from the perspective of precision nanomedicine","volume":"16","author":"Sierri","year":"2024","journal-title":"WIREs Nanomedicine and Nanobiotechnology"},{"key":"10.1016\/bs.irn.2026.05.016_bib104","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/antiox9080743","article-title":"ROS generation in microglia: Understanding oxidative stress and inflammation in neurodegenerative disease","volume":"9","author":"Simpson","year":"2020","journal-title":"Antioxidants"},{"key":"10.1016\/bs.irn.2026.05.016_bib105","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1039\/D4PM00174E","article-title":"Nose to brain targeting of the donepezil nanostructured lipid carrier in situ gel: Formulation, in vitro, ex vivo, in vivo pharmacokinetic and pharmacodynamic characterization","volume":"1","author":"Sonawane","year":"2024","journal-title":"RSC Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.01186","article-title":"The sigma-1 receptor: When adaptive regulation of cell electrical activity contributes to stimulant addiction and cancer","volume":"13","author":"Soriani","year":"2019","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/bs.irn.2026.05.016_bib107","doi-asserted-by":"crossref","first-page":"9212","DOI":"10.3390\/ijms23169212","article-title":"The role of bioenergetics in neurodegeneration","volume":"23","author":"Strope","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib108","doi-asserted-by":"crossref","first-page":"8142","DOI":"10.3390\/ijms22158142","article-title":"Brain glucose transporters: Role in pathogenesis and potential targets for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Szablewski","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib109","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.abb.2018.10.013","article-title":"Cardiolipin-targeted peptides rejuvenate mitochondrial function, remodel mitochondria, and promote tissue regeneration during aging","volume":"660","author":"Szeto","year":"2018","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.irn.2026.05.016_bib110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.irn.2026.05.016_bib111","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1021\/nn405077y","article-title":"Curcumin-loaded nanoparticles potently induce adult neurogenesis and reverse cognitive deficits in Alzheimer\u2019s disease model via canonical Wnt\/\u03b2-catenin pathway","volume":"8","author":"Tiwari","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/bs.irn.2026.05.016_bib112","doi-asserted-by":"crossref","first-page":"13302","DOI":"10.3390\/ijms252413302","article-title":"Nanoparticle strategies for treating CNS disorders: A comprehensive review of drug delivery and theranostic applications","volume":"25","author":"Toader","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib113","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpb.2008.09.026","article-title":"Multifunctional and stimuli-sensitive pharmaceutical nanocarriers","volume":"71","author":"Torchilin","year":"2009","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/bs.irn.2026.05.016_bib115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijpharm.2010.12.023","article-title":"Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells","volume":"406","author":"Ulbrich","year":"2011","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib116","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCRESAHA.119.316463","article-title":"Role of the GLUT1 glucose transporter in postnatal CNS angiogenesis and blood-brain barrier integrity","volume":"127","author":"Veys","year":"2020","journal-title":"Circulation Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103668","article-title":"Advances in cell-penetrating poly(disulfide)s for intracellular delivery of therapeutics","volume":"28","author":"Wan","year":"2023","journal-title":"Drug Discovery Today"},{"key":"10.1016\/bs.irn.2026.05.016_bib118","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1039\/C9NR01255A","article-title":"Curcumin-primed exosomes potently ameliorate cognitive function in AD mice by inhibiting hyperphosphorylation of the Tau protein through the AKT\/GSK-3\u03b2 pathway","volume":"11","author":"Wang","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/bs.irn.2026.05.016_bib119","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","article-title":"Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: Enhanced brain distribution and pharmacodynamics","volume":"106","author":"Wavikar","year":"2017","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.irn.2026.05.016_bib120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2008.01.039","article-title":"Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer\u2019s disease","volume":"1200","author":"Wilson","year":"2008","journal-title":"Brain Research"},{"key":"10.1016\/bs.irn.2026.05.016_bib121","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nano.2009.04.001","article-title":"Chitosan nanoparticles as a new delivery system for the anti-Alzheimer drug tacrine","volume":"6","author":"Wilson","year":"2010","journal-title":"Nanomedicine: Nanotechnology, Biology, and Medicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib122","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.2147\/IJN.S520768","article-title":"Brain delivery strategies for biomacromolecular drugs: Intranasal administration","volume":"20","author":"Wu","year":"2025","journal-title":"International Journal of Nanomedicine"},{"key":"10.1016\/bs.irn.2026.05.016_bib123","first-page":"1","article-title":"Shared mechanisms of neurodegeneration in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"2014","author":"Xie","year":"2014","journal-title":"BioMed Research International"},{"key":"10.1016\/bs.irn.2026.05.016_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2025.112913","article-title":"Mitochondrial dysfunction drives cellular senescence: Molecular mechanisms of inter-organelle communication","volume":"211","author":"Xie","year":"2025","journal-title":"Experimental Gerontology"},{"key":"10.1016\/bs.irn.2026.05.016_bib125","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202514522","article-title":"Nanomedicines against mitochondrial dysfunction\u2010induced metabolic diseases","volume":"12","author":"Xu","year":"2025","journal-title":"Advanced Science"},{"key":"10.1016\/bs.irn.2026.05.016_bib126","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.irn.2026.05.016_bib127","article-title":"Recent advances in nanotechnology for Parkinson\u2019s disease: Diagnosis, treatment, and future perspectives","volume":"12","author":"Yadav","year":"2025","journal-title":"Frontiers in Medicine\u00a0(Lausanne)"},{"key":"10.1016\/bs.irn.2026.05.016_bib128","article-title":"Exosome-mediated dual drug delivery of curcumin and methylene blue for enhanced cognitive function and mechanistic elucidation in Alzheimer\u2019s disease therapy","volume":"13","author":"Yang","year":"2025","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/bs.irn.2026.05.016_bib129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ijpharm.2013.05.009","article-title":"Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration","volume":"452","author":"Yang","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/bs.irn.2026.05.016_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103631","article-title":"Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study","volume":"75","author":"Yasir","year":"2022","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"10.1016\/bs.irn.2026.05.016_bib131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2022.09.017","article-title":"The barrier and interface mechanisms of the brain barrier, and brain drug delivery","volume":"190","author":"Zhang","year":"2022","journal-title":"Brain Research Bulletin"},{"key":"10.1016\/bs.irn.2026.05.016_bib132","doi-asserted-by":"crossref","first-page":"67","DOI":"10.37349\/en.2023.00013","article-title":"Metabolic correction of neurodegenerative pathologies: The role of macronutrients and timing","author":"Zilberter","year":"2023","journal-title":"Exploration of Neuroscience"}],"container-title":["International Review of Neurobiology","Brain Energy Metabolism in Alzheimers Disease - Part C"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774226000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:18:55Z","timestamp":1785874735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774226000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443345258"],"references-count":132,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2026.05.016","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}